Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

636 - The effects of 5-fluorouracil (5-FU) on TGF-β-related signaling molecules


11 Sep 2017


Poster display session


Cancer Biology


Ting Wang


Annals of Oncology (2017) 28 (suppl_5): v1-v21. 10.1093/annonc/mdx361


T. Wang1, Y. Takikawa2

Author affiliations

  • 1 Department Of Gestroenterology, Iwate Medical University School of Medicine, 020-8505 - Morioka/JP
  • 2 Department Of Gestroenterology, Iwate Medical University School of Medicine, Morioka/JP


Abstract 636


By identifying the mechanism of therapeutic effects of the combination of interferon alpha (IFNα)-2b and 5-fluorouracil (5-FU) on advanced hepatocellular carcinoma (HCC) with portal venous invasion1, we recently found that 5-FU increased both the expression and secretion of transforming growth factor (TGF)-β in HepG2 cells. In this study, we analyzed the effects of 5-FU on TGF-β-related signaling molecules.


Hepatoma cells (HepG2 and HuH7) were treated with 5-FU, IFNα-2b, and the combination of 5-FU and IFNα-2b. The total and/or phosphorylated protein levels of TGF-β-related signaling molecules were detected by western blot analysis. Additionally, the effects of above-mentioned treatments on the epithelial–mesenchymal transition (EMT) of the cells were evaluated by performing invasion and migration assays.


With respect to the TGF-β-induced apoptosis signals, 5-FU inhibited not only the phosphorylation of SMAD2, but also reduced the total protein levels of SMAD2, SMAD4, and pINK4b. Conversely, 5-FU stimulated the phosphorylation of TGF-β-induced EMT molecules, such as ERK and JNK, but not p38MAPK. Accordingly, the protein levels of E-cadherin were reduced in the cells treated with 5-FU. On the other hand, IFNα-2b did not affect the levels of TGF-β-induced EMT molecules, whereas the combination of 5-FU and IFNα-2b neutralized the effects of 5-FU on TGF-β-related signaling molecules and restored their protein levels to those observed in the control. Interestingly, the phosphorylated protein levels of SMAD2 and the total protein levels of E-cadherin and p15INK4b increased in 5-FU-stimulated HUH7 cells, but not in HepG2 cells. Furthermore, 5-FU stimulated both cell invasion and migration in HepG2 cells, whereas the combination of 5-FU and IFNα-2b abolished these effects of 5-FU.


Our data suggest that 5-FU induces the EMT of hepatoma cells through TGF-β, and that the higher efficacy of the combination therapy of 5-FU and IFNα-2b results from the inhibition of these effects of TGF-β. The differences observed between HepG2 and HUH7 cells in response to the stimulation with 5-FU indicate that the efficacy of the therapy may differ between patients with hepatitis B (HBV) or C virus (HCV) background.

Clinical trial identification

Legal entity responsible for the study

Iwate Medical University


Japan Society for the Promotion of Science (JSPS)


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.